• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The importance of combined radiation and endocrine therapy in locally advanced prostate cancer.

作者信息

Gray Phillip J, Shipley William U

机构信息

Harvard Radiation Oncology Program, Boston, MA 02114, USA.

出版信息

Asian J Androl. 2012 Mar;14(2):245-6. doi: 10.1038/aja.2011.177. Epub 2011 Dec 26.

DOI:10.1038/aja.2011.177
PMID:22198629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3735089/
Abstract
摘要

相似文献

1
The importance of combined radiation and endocrine therapy in locally advanced prostate cancer.联合放疗与内分泌治疗在局部晚期前列腺癌中的重要性。
Asian J Androl. 2012 Mar;14(2):245-6. doi: 10.1038/aja.2011.177. Epub 2011 Dec 26.
2
Endocrine treatment of prostate cancer.前列腺癌的内分泌治疗
J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31.
3
Risk-based management of prostate cancer.基于风险的前列腺癌管理
N Engl J Med. 2011 Jul 14;365(2):169-71. doi: 10.1056/NEJMe1103829.
4
Hormone therapy in advanced prostate cancer.晚期前列腺癌的激素治疗
Front Radiat Ther Oncol. 2002;36:49-65. doi: 10.1159/000061329.
5
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.前列腺局部晚期癌根治性放疗联合雄激素剥夺辅助治疗的III期放射肿瘤学组（RTOG）86-10试验。
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1243-52. doi: 10.1016/s0360-3016(01)01579-6.
6
Hormonal treatment of prostate cancer.前列腺癌的激素治疗
N Engl J Med. 1999 Mar 11;340(10):812-3. doi: 10.1056/NEJM199903113401015.
7
Endocrine therapy for prostate cancer.前列腺癌的内分泌治疗
Endocrinol Metab Clin North Am. 1991 Dec;20(4):845-72.
8
[Combined external radiotherapy and hormone therapy in patients with locally advanced prostate cancer: predictive factors of genitourinary toxicity].
Actas Urol Esp. 2011 Mar;35(3):146-51. doi: 10.1016/j.acuro.2010.08.006. Epub 2011 Feb 18.
9
Advanced prostate cancer. Hormonal treatment.晚期前列腺癌。激素治疗。
Tunis Med. 2005 Dec;83 Suppl 12:71-3.
10
Current concepts in androgen deprivation therapy--is there a "best" endocrine treatment?
World J Urol. 2000 Jun;18(3):190-3. doi: 10.1007/s003459900099.

引用本文的文献

1
The opportunity cost of androgen suppression in locally advanced prostate cancer.局部晚期前列腺癌雄激素抑制的机会成本。
Asian J Androl. 2013 May;15(3):356-7. doi: 10.1038/aja.2012.166. Epub 2013 Feb 25.
2
Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: a comparison with clinically localized prostate cancer.根治性耻骨后前列腺切除术治疗局部晚期前列腺癌的围手术期并发症：与临床局限性前列腺癌的比较。
Asian J Androl. 2013 Mar;15(2):241-5. doi: 10.1038/aja.2012.120. Epub 2012 Dec 10.

本文引用的文献

1
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.联合雄激素剥夺疗法和放射治疗局部晚期前列腺癌：一项随机、3 期试验。
Lancet. 2011 Dec 17;378(9809):2104-11. doi: 10.1016/S0140-6736(11)61095-7. Epub 2011 Nov 2.
2
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer.调强放疗可降低接受雄激素剥夺治疗的前列腺癌患者的胃肠道毒性。
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):437-44. doi: 10.1016/j.ijrobp.2010.02.040. Epub 2010 Nov 2.
3
Cancer statistics, 2010.癌症统计数据，2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
4
Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.英国基于人群的前列腺特异性抗原检测导致前列腺癌的分期迁移。
BJU Int. 2009 Dec;104(11):1592-8. doi: 10.1111/j.1464-410X.2009.08652.x. Epub 2009 Jun 19.
5
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
Lancet Oncol. 2009 Apr;10(4):370-80. doi: 10.1016/S1470-2045(09)70027-0. Epub 2009 Mar 13.
6
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.局部晚期前列腺癌的内分泌治疗（联合或不联合放疗）（SPCG-7/SFUO-3）：一项开放随机III期试验
Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Epub 2008 Dec 16.
7
Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.调强放射治疗在局部前列腺癌剂量递增中降低毒性方面的作用。
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):685-91. doi: 10.1016/j.ijrobp.2008.04.063. Epub 2008 Aug 19.
8
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.局部晚期前列腺癌的短期新辅助雄激素剥夺疗法与外照射放疗：RTOG 8610的长期结果
J Clin Oncol. 2008 Feb 1;26(4):585-91. doi: 10.1200/JCO.2007.13.9881. Epub 2008 Jan 2.
9
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.基于2000年至2005年的病例，更新了列线图，以根据前列腺特异性抗原水平、临床分期和活检Gleason评分（Partin表）预测前列腺癌的病理分期。
Urology. 2007 Jun;69(6):1095-101. doi: 10.1016/j.urology.2007.03.042.
10
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.一项比较全盆腔放疗与仅前列腺放疗以及新辅助全雄激素抑制与辅助全雄激素抑制的III期试验的更新：RTOG 94-13的更新分析，重点关注意外的激素/放疗相互作用。
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):646-55. doi: 10.1016/j.ijrobp.2007.04.003. Epub 2007 May 24.